The enigma of ceramide synthase regulation in mammalian cells

详细信息    查看全文

• 作者：Marthe-Susanna Wegner^a ; ^{wegner@med.uni-frankfurt.de" class="auth_mail" title="E-mail the corresponding author} ; Susanne Schiffmann^b ; Michael John Parnham^b ; Gerd Geisslinger^a ; Sabine Grö ; sch^a
• 关键词：Ceramide synthases ; Transcriptional ; miR ; Post-translational ; Epigenetic ; Regulation
• 刊名：Progress in Lipid Research
• 出版年：2016
• 出版时间：July 2016
• 年：2016
• 卷：63
• 期：Complete
• 页码：93-119
• 全文大小：1937 K

文摘

Ceramide synthases (CerS) are key enzymes in the lipid metabolism of eukaryotic cells. Their products, ceramides (Cer), are components of cellular membranes but also mediate signaling functions in physiological processes such as proliferation, skin barrier function and cerebellar development. In pathophysiological processes such as multiple sclerosis and tumor progression, ceramide levels are altered, which can be ascribed, partly, to dysregulation of CerS gene transcription. Most publications deal with the effects of altered ceramide levels on physiological and pathophysiological processes, but the regulation of the appropriate CerS is frequently not investigated. This is insufficient for the clarification of the role of ceramides, because most ceramide species are generated by at least two CerS. The mechanisms of CerS regulation are manifold and it seems that each CerS isoform is regulated individually. For this reason, we discuss the different CerS separately in this review. From transcriptional regulation to alteration of protein activity, the possibilities to influence CerS are diverse. Furthermore, CerS are influenced by a variety of molecules including hormones and lipids. Without claiming completeness, we provide a résumé of the regulatory mechanisms for each CerS in mammalian cells and how dysregulation of these mechanisms during physiological processes may lead to pathophysiological processes.